Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Operating Income (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Operating Income for 11 consecutive years, with -$56.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Income fell 345.86% year-over-year to -$56.5 million, compared with a TTM value of -$215.4 million through Dec 2025, down 95.09%, and an annual FY2025 reading of -$215.4 million, down 95.09% over the prior year.
  • Operating Income was -$56.5 million for Q4 2025 at Wave Life Sciences, roughly flat from -$56.4 million in the prior quarter.
  • Across five years, Operating Income topped out at $23.0 million in Q4 2024 and bottomed at -$63.9 million in Q3 2024.
  • Average Operating Income over 5 years is -$34.2 million, with a median of -$38.5 million recorded in 2022.
  • Peak annual rise in Operating Income hit 222.94% in 2024, while the deepest fall reached 1538.23% in 2024.
  • Year by year, Operating Income stood at -$36.1 million in 2021, then decreased by 20.64% to -$43.6 million in 2022, then soared by 57.11% to -$18.7 million in 2023, then soared by 222.94% to $23.0 million in 2024, then plummeted by 345.86% to -$56.5 million in 2025.
  • Business Quant data shows Operating Income for WVE at -$56.5 million in Q4 2025, -$56.4 million in Q3 2025, and -$52.8 million in Q2 2025.